1. Home
  2. NYAX vs BEAM Comparison

NYAX vs BEAM Comparison

Compare NYAX & BEAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nayax Ltd.

NYAX

Nayax Ltd.

N/A

Current Price

$48.36

Market Cap

2.6B

Sector

N/A

ML Signal

N/A

Logo Beam Therapeutics Inc.

BEAM

Beam Therapeutics Inc.

HOLD

Current Price

$23.99

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NYAX
BEAM
Founded
2005
2017
Country
Israel
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
2.6B
IPO Year
2022
2019

Fundamental Metrics

Financial Performance
Metric
NYAX
BEAM
Price
$48.36
$23.99
Analyst Decision
Buy
Strong Buy
Analyst Count
6
15
Target Price
★ $75.66
$52.15
AVG Volume (30 Days)
22.2K
★ 1.5M
Earning Date
11-18-2026
11-03-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 82.31
EPS
★ N/A
N/A
Revenue
N/A
★ $24,000.00
Revenue This Year
$29.66
N/A
Revenue Next Year
$24.15
$29.19
P/E Ratio
$89.78
★ N/A
Revenue Growth
N/A
★ 33.33
52 Week Low
$39.17
$20.23
52 Week High
$76.86
$38.26

Technical Indicators

Market Signals
Indicator
NYAX
BEAM
Relative Strength Index (RSI) 55.79 44.66
Support Level $45.59 $22.65
Resistance Level $50.30 $26.72
Average True Range (ATR) 1.07 1.20
MACD 0.63 0.07
Stochastic Oscillator 82.37 23.15

Price Performance

Historical Comparison
NYAX
BEAM

About NYAX Nayax Ltd.

Nayax Ltd is an end-to-end retail technology platform for unattended commerce. It unifies payments, operations management, and customer engagement tools into a powerful, adaptable platform for modern commerce. It provides solutions that empower businesses to enhance customer experience, accept cashless payments, and manage their operations with a robust Internet of Things (IoT) software platform, helping achieve long-term growth. The company addresses a broad range of retail verticals, including all types of vending machines, coffee machines, unattended checkout counters, self-service kiosks, ticketing machines, car wash stations, gaming machines, amusement rides, laundromats, EV charging stations, and many more.

About BEAM Beam Therapeutics Inc.

Beam Therapeutics Inc is a biotechnology company committed to creating a new class of precision genetic medicines based on its proprietary base editing technology, with a vision of providing lifelong cures to patients suffering from serious diseases. The company is focused on its programs in the hematology and genetic disease portfolios, which comprise different product candidates in its pipeline, such as BEAM-101, which is being developed to target Sickle Cell Disease, BEAM-302, a liver-targeting lipid nanoparticle, being developed to target Alpha-1 antitrypsin deficiency, and other drug candidates including BEAM-302, BEAM-103 & 104. The company operates and manages its business in one operating segment, United States.

Share on Social Networks: